相似文献
1
The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated.氟替卡松鼻喷雾剂对新型冠状病毒肺炎相关嗅觉减退的作用仍未得到证实。
Am J Otolaryngol. 2021 Jul-Aug;42(4):103008. doi: 10.1016/j.amjoto.2021.103008. Epub 2021 Mar 24.
2
Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".致编辑的信：关于“氟替卡松鼻喷雾剂对新冠患者嗅觉丧失的疗效及曲安奈德口腔糊剂对味觉障碍的疗效”
Am J Otolaryngol. 2021 Sep-Oct;42(5):103103. doi: 10.1016/j.amjoto.2021.103103. Epub 2021 Jun 5.
3
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.COVID-19 患者中，氟替卡松鼻喷雾剂对嗅觉丧失和曲安奈德口腔糊剂对味觉障碍的疗效。
Am J Otolaryngol. 2021 May-Jun;42(3):102892. doi: 10.1016/j.amjoto.2020.102892. Epub 2021 Jan 16.
4
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients.氟替卡松鼻喷雾剂对新冠病毒感染患者嗅觉丧失的疗效及曲安奈德口腔糊剂对味觉障碍的疗效
Am J Otolaryngol. 2021 Jul-Aug;42(4):103009. doi: 10.1016/j.amjoto.2021.103009. Epub 2021 Apr 5.
5
Anosmia (smell failure) and dysgeusia (taste distortion) in COVID-19: it is genetic.新冠病毒引发的嗅觉丧失（嗅觉失灵）和味觉障碍（味觉失真）：这是由基因导致的。
J Biomol Struct Dyn. 2023 Apr;41(7):3162-3165. doi: 10.1080/07391102.2022.2039773. Epub 2022 Feb 11.
6
Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.新冠疫情期间嗅觉丧失和味觉障碍的发病机制和进展。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):505-509. doi: 10.1007/s00405-022-07689-w. Epub 2022 Oct 9.
7
Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.比较任何形式的类固醇与其他药物对 COVID-19 患者嗅觉功能障碍持续时间的影响：随机试验和准实验研究的系统评价。
PLoS One. 2023 Aug 2;18(8):e0288285. doi: 10.1371/journal.pone.0288285. eCollection 2023.
8
Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19.五钠二乙撑三胺五乙酸改善 COVID-19 后嗅觉丧失的疗效。
Am J Otolaryngol. 2023 Jul-Aug;44(4):103871. doi: 10.1016/j.amjoto.2023.103871. Epub 2023 Mar 30.
9
COVID-19 Anosmia Reporting Tool: Initial Findings.COVID-19 嗅觉丧失报告工具：初步研究结果。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134. doi: 10.1177/0194599820922992. Epub 2020 Apr 28.
10
[Smell impairment in COVID-19 patients: mechanisms and clinical significance].[新冠病毒感染患者的嗅觉障碍：机制与临床意义]
Vestn Otorinolaringol. 2020;85(5):93-97. doi: 10.17116/otorino20208505193.
引用本文的文献
1
Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic.针对新冠病毒相关持续性嗅觉障碍的疗法：疫情带来的一项积极成果。
Pathogens. 2023 Jan 3;12(1):72. doi: 10.3390/pathogens12010072.
2
Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic.病毒感染后嗅觉丧失：我们从新冠疫情中学到的经验
Life (Basel). 2022 Nov 12;12(11):1868. doi: 10.3390/life12111868.
3
The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients.持续性嗅觉和味觉功能障碍对新冠长期患者生活质量的影响。
Life (Basel). 2022 Jan 19;12(2):141. doi: 10.3390/life12020141.
4
Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19).用于治疗 SARS-CoV2 感染（COVID-19）的现有和新兴免疫调节剂。
Expert Opin Pharmacother. 2022 Apr;23(5):623-628. doi: 10.1080/14656566.2022.2035360. Epub 2022 Feb 1.
5
The study of recovery rates of COVID-19 olfactory and gustatory dysfunctions requires psychophysical evaluations.对新冠病毒嗅觉和味觉功能障碍恢复率的研究需要进行心理物理学评估。
Am J Otolaryngol. 2021 Nov-Dec;42(6):103168. doi: 10.1016/j.amjoto.2021.103168. Epub 2021 Jul 29.
本文引用的文献
1
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.COVID-19 患者中，氟替卡松鼻喷雾剂对嗅觉丧失和曲安奈德口腔糊剂对味觉障碍的疗效。
Am J Otolaryngol. 2021 May-Jun;42(3):102892. doi: 10.1016/j.amjoto.2020.102892. Epub 2021 Jan 16.
2
Objective gustatory and olfactory dysfunction in COVID-19 patients: a prospective cross-sectional study.目的：研究 COVID-19 患者味觉和嗅觉功能障碍：一项前瞻性横断面研究。
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3325-3332. doi: 10.1007/s00405-020-06590-8. Epub 2021 Jan 20.
3
Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts.COVID-19 患者嗅觉丧失：MRI 数据显示嗅裂短暂性水肿。
Neurology. 2020 Dec 8;95(23):e3145-e3152. doi: 10.1212/WNL.0000000000010806. Epub 2020 Sep 11.
4
Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.目的：对 86 例 COVID-19 患者的嗅觉自我报告丧失病例系列进行客观嗅觉评估。
Head Neck. 2020 Jul;42(7):1583-1590. doi: 10.1002/hed.26279. Epub 2020 May 21.
5
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病（COVID-19）轻至中度形式的临床特征：一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
6
Genetic and environmental influences on odor identification ability in the very old.遗传和环境因素对高龄人群嗅觉识别能力的影响。
Psychol Aging. 2011 Dec;26(4):864-71. doi: 10.1037/a0023263. Epub 2011 May 30.
7
A comparison of methods for sniff measurement concurrent with olfactory tasks in humans.
Chem Senses. 2006 Nov;31(9):795-806. doi: 10.1093/chemse/bjl021. Epub 2006 Aug 16.
8
Olfactory dysfunction and its measurement in the clinic and workplace.嗅觉功能障碍及其在临床和工作场所的测量。
Int Arch Occup Environ Health. 2006 Apr;79(4):268-82. doi: 10.1007/s00420-005-0055-6. Epub 2006 Jan 21.
9
Assessment of gustatory function by means of tasting tablets.通过味觉片评估味觉功能。
Laryngoscope. 2000 Aug;110(8):1396-401. doi: 10.1097/00005537-200008000-00033.
Zotero 插件